Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach

被引：0

作者：

Lassen, U. N. ^{[1
]}

Albert, C. M. ^{[2
]}

Kummar, S. ^{[3
]}

van Tilburg, C. M. ^{[4
,5
]}

Dubois, S. G. ^{[6
]}

Geoerger, B. ^{[7
]}

Mascarenhas, L. ^{[8
]}

Federman, N. ^{[9
]}

Schilder, R. J. ^{[10
]}

Doz, F. ^{[11
,12
]}

Berlin, J. D. ^{[13
]}

Oh, D-Y. ^{[14
]}

Bielack, S. S. ^{[15
]}

McDermott, R. ^{[16
]}

Tan, D. S. ^{[17
]}

Cruickshank, S. ^{[18
]}

Ku, N. C. ^{[18
]}

Cox, M. C. ^{[18
]}

Drilon, A. ^{[19
]}

Hong, D. S. ^{[20
]}

机构：

[1] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Finsen Ctr,Phase Unit 1, Copenhagen, Denmark

[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Childrens Hosp, Pediat Oncol, Seattle, WA 98195 USA

[3] Stanford Univ, Stanford Canc Inst, Med Oncol, Stanford, CA 94305 USA

[4] Univ Heidelberg Hosp, Hopp Childrens Canc Ctr, NCT Heidelberg KiTZ, Pediat Oncol, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] Dana Farber Boston Childrens Canc & Blood Disorde, Pediat Oncol, Boston, MA USA

[7] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France

[8] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Oncol, Los Angeles, CA 90033 USA

[9] Univ Calif Los Angeles, Pediat Oncol, Los Angeles, CA USA

[10] Thomas Jefferson Univ, Med Oncol, Philadelphia, PA 19107 USA

[11] Inst Curie, Pediat Oncol, Paris, France

[12] Univ Paris 05, Paris, France

[13] Vanderbilt Ingram Canc Ctr, Med, Nashville, TN USA

[14] Seoul Natl Univ Hosp, Med Oncol, Seoul, South Korea

[15] Klinikum Stuttgart, Pediat Oncol, Olgahosp, Stuttgart, Germany

[16] AMNCH Adelaide & Meath Hosp, Med Oncol, Dublin, Ireland

[17] Natl Canc Ctr, Med Oncol, Singapore, Singapore

[18] Loxo Oncol, Clin Dev, San Francisco, CA USA

[19] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA

[20] Univ Texas MD Anderson Canc Ctr, Med Oncol, Houston, TX 77030 USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

409O

引用

页码：133 / 133

页数：1

共 50 条

[21] Activity and safety of larotrectinib in adult patients with TRK fusion cancer: an expanded data set
Leyvraz, S.
Drilon, A.
Farago, A. F.
Tan, D. S. W.
Kummar, S.
McDermott, R.
Berlin, J.
Patel, J.
Brose, M. S.
Tahara, M.
Benjamin, S.
Reeves, J. A.
Fellous, M.
Brega, N.
Childs, B. H.
Lassen, U.
Hong, D. S.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 230 - 231
[22] EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET
Perreault, Sebastien
Doz, Francois
Drilon, Alexander
Geoerger, Birgit
Boni, Valentina
Chisholm, Julia
Dubois, Steven G.
Grilley-Olson, Juneko E.
Hong, David S.
Italiano, Antoine
Kang, HyoungJin
Nysom, Karsten
Ora, Ingrid
Owens, Cormac
Schulte, Johannes H.
Tahara, Makoto
Ziegler, David
Ellezam, Benjamin
Reeves, John A.
Fellous, Marc
De La Cuesta, Esther
Laetsch, Theodore W.
van Tilburg, Cornelis M.
NEURO-ONCOLOGY, 2020, 22 : 58 - 58
[23] Activity and safety of larotrectinib in adult patients with TRK fusion cancer: An expanded data set.
Drilon, Alexander E.
Farago, Anna F.
Tan, Daniel Shao-Weng
Kummar, Shivaani
McDermott, Raymond S.
Berlin, Jordan
Patel, Jyoti D.
Brose, Marcia S.
Leyvraz, Serge
Tahara, Makoto
Solomon, Benjamin Maurice
Reeves, John A.
Fellous, Marc Mardoche
Brega, Nicoletta
Childs, Barrett H.
Lassen, Ulrik Niels
Hong, David S.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[24] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset
Boni, V.
Drilon, A.
Deeken, J.
Garralda, E.
Chung, H.
Kinoshita, I.
Oh, D.
Patel, J.
Xu, R.
Norenberg, R.
Brega, N.
Dima, L.
Hong, D.
Berlin, J.
ANNALS OF ONCOLOGY, 2021, 32 : S214 - S215
[25] Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U. N.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
ANNALS OF ONCOLOGY, 2020, 31 : S834 - S834
[26] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Tan, D.
Farago, A.
Kummar, S.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Reeves, J.
Brega, N.
Dima, L.
Childs, B.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S176 - S176
[27] Efficacy and Safety of Larotrectinib in Patients with Tropomyosin Receptor Kinase (TRK) Fusion Lung Cancer
Drilon, A.
Moreno, V.
Patel, J.
Lassen, U.
Solomon, B.
Rosen, L.
Leyvraz, S.
Tan, D. S. W.
Reeves, J. A.
Dima, L.
Brega, N.
Kummar, S.
Farago, A. F.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S30 - S31
[28] Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase (TRK) fusion cancer
Brose, M. S.
Shen, L.
Tan, D. S. W.
Kummar, S.
Lin, J. J.
McDermott, R.
Berlin, J.
Tahara, M.
Lassen, U. N.
Leyvraz, S.
Patel, J. D.
Norenberg, R.
Dima, L.
Brega, N.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2021, 32 : S600 - S601
[29] Efficacy and Safety of Larotrectinib in Pediatric Patients with Non-Central Nervous System (CNS) Tropomyosin Receptor Kinase (TRK) Fusion-Positive Cancer: An Expanded Dataset
Van Tilburg, C.
Albert, C.
Bielack, S.
Dubois, S.
Federman, N.
Geoerger, B.
Nagasubramanian, R.
Pappo, A.
Norenberg, R.
Dima, L.
De La Cuesta, E.
Zhang, Y.
Doz, F.
Laetsch, T.
PEDIATRIC BLOOD & CANCER, 2021, 68 : S54 - S54
[30] Updated Efficacy, Safety, and Biomarker Analysis in Patients with TRK Fusion Lung Cancer Treated with Larotrectinib
Lin, J. J.
Tan, D. S. W.
Kummar, S.
Moreno, V.
Leyvraz, S.
Dubashi, B.
Parambath, H.
Burcoveanu, D. -I.
Neu, N.
Leserer, S.
Seidel, H.
Mussi, C. E.
Shen, L.
Drilon, A.
JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S77 - S77

← 1 2 3 4 5 →